HPRT1 and Parkinson disease: As a main finding, the integrated network analysis also highlighted a potential key enzyme, HPRT1, which catalyzes the conversion of hypoxanthine to IMP, and whose decreased abundance in PD may explain the increased metabolite abundances observed in the alternative hypoxanthine-to-xanthine pathway (see Fig. 6).